4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001209191-15-048129
Options or other derivatives
- Chief Scientific Officer acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| CHAPLIN DAVID Chief Scientific Officer | 2015-05-28 | Grant or award · Employee Stock Option (Right to Buy) | +225,000 | 225,000 | D | ||
Loading xslF345X03/doc4.xml…